Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure

This publication has 30 references indexed in Scilit:

• The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.
  British Journal of Clinical Pharmacology, 1986
• Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
  Heart, 1985
• The effects of dopexamine on the cardiovascular system of the dog
  British Journal of Pharmacology, 1985
• Dopexamine: a novel agonist at peripheral dopamine receptors and β₂‐adrenoceptors
  British Journal of Pharmacology, 1985
• Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.
  Circulation, 1984
• Multiple receptors for dopamine
  Nature, 1979
• Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
  Circulation, 1978
• Comparison of dobutamine and dopamine in treatment of severe heart failure.
  Heart, 1977
• Direct Renal Vasodilatation Produced by Dopamine in the Dog
  Circulation Research, 1965
• Re-examination of salt and water retention in congestive heart failure: Significance of renal filtration fraction
  The American Journal of Medicine, 1958